The largest database of trusted experimental protocols

B 27 serum free supplement

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Germany

B-27 supplement is a serum-free, chemically defined supplement designed to support the growth and survival of neuronal cells in cell culture. It provides a wide range of essential nutrients, vitamins, and antioxidants to promote the optimal growth and differentiation of neurons.

Automatically generated - may contain errors

172 protocols using b 27 serum free supplement

1

Directed Differentiation of hiPS Cells to Intermediate Mesoderm

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue-culture-treated plates (12-well polystyrene plates, VWR, Radnor, PA, USA) were incubated with 5 µg/mL laminin-511-E8 solution (iMatrix-511) in sterile water for 3 h at room temperature. hiPS cells were dissociated from Matrigel-coated plates by treatment with enzyme-free cell dissociation buffer (Thermo Fisher Scientific, Waltham, MA, USA) and centrifuged (Avanti J15-R, Beckman-Coulter, Pasadena, CA, USA) at 200 g for 5 min in DMEM/F12. Then, the cells were resuspended in a mesoderm differentiation medium containing DMEM/F12 with GlutaMax (GIBCO) supplemented with 100 ng/mL activin A (Thermo Fisher Scientific, Waltham, MA, USA), 3 µM CHIR99021 (Stemgent, Cambridge, MA, USA), 10 µM Y27632 (TOCRIS, Minneapolis, MN, USA), and 1 × B27 serum-free supplement (GIBCO, Waltham, MA, USA), and 100,000 cells were plated onto each well of a 12-well plate coated with the laminin-511-E8 solution. After 2 days of differentiation, the cell culture medium was switched to an intermediate mesoderm induction medium containing DMEM/F12 with GlutaMax supplemented with 100 ng/mL BMP7 (Thermo Fisher Scientific, Waltham, MA, USA), 3 µM CHIR99021, and 1 × B27 serum-free supplement, and the cells were incubated for a minimum of 14 days with daily medium replenishment.
+ Open protocol
+ Expand
2

Primary Neuronal Cell Isolation from Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain primary neuronal cells, male and female mice were mated. If a vaginal plug was observed the next morning, it was designated as embryonic day (E0.5). Embryos were collected at day E15.5 from a pregnant dam and brains were obtained. Meninges were discarded and forebrains were collected in Hibernate®-E (Thermo Scientific, Waltham, MA, USA) supplemented with 2% B-27® Serum-Free Supplement (Thermo Scientific) and 0.5 mM GlutaMAX™-I (Thermo Scientific) at 4 °C. Next, brains were washed two times with Hanks’ Balanced Salt Solution (HBSS, PAN-BioTech, Aidenbach, Germany). Afterwards, they were thoroughly resuspended in Neurobasal medium supplemented with 2% B-27® Serum-Free Supplement (Thermo Scientific) and 0.5 mM GlutaMAX™-I (Thermo Scientific) and seeded on poly L-ornithine coated plates. Every three-four days half of the medium was aspirated and replaced with fresh Neurobasal medium. At days in vitro 7 (DIV7) neurons were treated with RCM/MCM or EGF as described below.
+ Open protocol
+ Expand
3

Neural Lineage Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five-thousand cells were dissociated as described above, plated in eight-well chamber slides coated with poly-L-ornithine and laminin, and incubated for 1 day in stem cell media, containing KnockOut D-MEM/F12, GlutaMax-I supplement [2 mM), bFGF (20 ng/ml), EGF (20 ng/ml), 2% StemPro Neural Supplement, penicillin/streptomycin (0.1%) and Fungizone (40 ng/ml)]. Media were then replaced by neuronal differentiation medium [Neurobasal medium, 2% B27 Serum-Free Supplement (ThermoFisher Scientific, 17504), GlutaMax-I supplement (2 mM)], Astrocyte differentiation medium [D-MEM, 1% N-2 Supplement (ThermoFisher Scientific, 17502), GlutaMax-I supplement (2 mM), 1% FBS) or oligodendrocyte differentiation medium [Neurobasal medium, 2% B-27 Serum-Free Supplement (ThermoFisher Scientific, 17504), GlutaMax-I supplement (2 mM), T3 (Sigma, cat. D6397)]. Media were replaced every 2 days for 10 DIV. Cells were fixed with 4% PFA for 15 min at room temperature and immunostained using mouse anti-Tuj1 antibody (neuronal III β-tubulin, 1/500, Covance, MMS-435P), goat anti-Pdgfrα antibody (1/500, R&D Systems, AF1062) or rabbit anti-S100b antibody (1/500, Dako, Z031129). Secondary antibodies were conjugated to Alexa fluor 568 (Molecular Probes) or Alexa fluor 488 (Molecular Probes).
+ Open protocol
+ Expand
4

Isolation and Differentiation of Rat Neurospheres

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sub-ventricular areas were taken from the brains of the newborn rats. The SVZs was digested for 5 min at 37 °C in 0.002% deoxyribonuclease I (Sigma) plus 0.02% trypsin (Invitrogen), then were isolated into individual cells with a Pasteur pipette, It was then cultured in DMEM / F12 (Dulbecco's Modified Eagle Medium F12) (Gibco) with 2% B-27 serum-free supplement (Gibco), 1% streptomycin (Invitrogen), 1% penicillin (Invitrogen) and 2 mMLglutamine (Gibco) for 24 h. the cells were grown for 2 weeks in 20 ng/ml hEGF (Calbiochem) and 20 ng/ml hFGF (Pasteur Institute). During culture, cells grew as spherical structures (neurospheres). The cells were passaged for 14 days [4] . For differentiation NSCs into Noradrenergic-like cells, NSCs were cultured in Neurobasal Culture medium (Gibco) with B-27serum-free supplement (Gibco) and 0.5 mM L-glutamine (Gibco). Trophic factors GDNF (30 ng/ml, Sigma) and BDNF (50 ng/ml; Sigma) Added for 5 days [6, 18] (link).
+ Open protocol
+ Expand
5

iPSK3 Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated human iPSK3 cells were seeded into ultra-low attachment (ULA) 24-well plates (Corning Inc., Corning, NY) at 3 × 105 cells/well in differentiation medium composed of DMEM/F-12 plus 2% B27 serum-free supplement (Life Technologies, Carlsbad, CA). iPSK3 cells were seeded in the presence of Y27632 (10 μM). After 24 h, Y27632 was removed and the formed embryoid bodies (EB) were treated with dual SMAD signaling inhibitors of 10 μM SB431542 (Sigma-Aldrich, St. Louis, MO) and 100 nM LDN193189 (Sigma) over 7 days. Then on day 8, the spheroids were treated with fibroblast growth factor (FGF)-2 (10 ng/mL, Life Technologies) and cyclopamine (an Shh inhibitor, 1 μM, Sigma) for cortical differentiation for 21 days.22 (link),33 (link),34 (link) The cells were replated onto growth factor reduced Matrigel-coated surfaces and treated with different iron oxide nanoparticles for another 2–4 days prior to further downstream experiments (Figure 1B, C). On the basis of our previous studies,35 (link),36 (link) the labeling efficiency for microsized particles of iron oxides (MPIO) can reach 50–80%. It was estimated that the labeling efficiency for nanoscale iron oxides should be similar or higher than MPIO.
+ Open protocol
+ Expand
6

Neuroprotective Effects of Autophagy in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pregnant C57BL/6J mice (17–18 days of gestation) and adult mice (6–8 weeks old, 25–30 g) were purchased from the Experimental Animal Center of Peking Union Medical College. Experiments were approved by the Institutional Animal Care and Use Committee of Tianjin Huanhu Hospital. l-Glutamine, 3-methyladenine (3-MA), poly-d-lysine, and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay kit were purchased from Sigma Company (St. Louis, MO, USA). Rabbit anti-mouse LC3, Akt, and phospho-Akt antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Enhanced chemiluminescence (ECL) reagents were purchased from Millipore Company (USA). Fetal bovine serum (FBS), neurobasal medium, B-27 serum-free supplement, Dulbecco’s modified Eagle’s medium (DMEM)/F-12 medium, trypsin, rapamycin, and wortmannin were purchased from Life Technologies (Carlsbad, CA, USA). The Akt inhibitor GDC-0068 was purchased from Selleckchem. Glucose-free DMEM was purchased from Gibco Company (USA).
+ Open protocol
+ Expand
7

Directed Differentiation of Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSK3 cells were seeded into Ultra-Low Attachment 24-well plates (Corning Incorporated, Corning, NY, USA) at 3 × 105 cells/well in 1 mL of differentiation medium composed of Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) plus 2% B27 serum-free supplement (Life Technologies). Y27632 (10 µM) was added during the seeding and removed after 24 h. At day 1, the cells formed embryoid bodies (EBs) and were treated with dual SMAD signaling inhibitors 10 µM SB431542 (Sigma) and 100 nM LDN193189 (Sigma) [53 (link),54 (link),58 (link)]. After eight days, the cells were treated with fibroblast growth factor (FGF)-2 (10 ng/mL, Life Technologies) and retinoic acid (RA) (5 µM, Sigma) until day 16. At day 17 the spheroids were replated onto Geltrex-coated cell plates. The conditioned media from day 15–20 culture were collected 48 h after the previous medium change.
+ Open protocol
+ Expand
8

Cardiomyocyte Differentiation from iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were differentiated into cardiomyocytes as a monolayer through the modulation of WNT signaling. iPSCs were plated at low density on Matrigel coated plates to have them 70–80% confluent after 4 days (Day 1 of differentiation). Differentiation was induced with 3 ml of RPMI 1640 (Life Technologies 11875-093) with 1X B27® Minus insulin (Life Technologies 0050129SA), supplemented with 6 μM CHIR (TOCRIS 4953). On day 6, media was replaced with 3 ml of RPMI 1640 with 1X B27® Minus insulin, supplemented with 5 μM IWR. From day 8, cells were kept in RPMI 1640 (Life Technologies 11875-093) with 1X B27® Serum-Free Supplement (Life Technologies 17504-044). From days 12–15 cells were treated with RPMI 1640 no Glucose (Life Technologies 11879-020) with 1X B27, then allowed to recover for 2 days in RPMI 1640 with 1X B27, and subsequently replanted at a density of 3Mi cells/well. Cells were then maintained in RPMI 1640 with 1X B27 for 4 more weeks before being collected for the experiment.
+ Open protocol
+ Expand
9

SH-SY5Y Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated adherent SH-SY5Y cells were grown in Dulbecco's Modified Eagle Medium (Thermo Scientific, Rockford, IL) with 10% FBS (Thermo Scientific, Rockford, IL), 2 mM L-alanyl-L-glutamine (Sigma-Aldrich, Missouri, USA), and 1x Penicillin Streptomycin (Thermo Scientific, Rockford, IL) and were maintained under 37°C and 5% CO2 conditions. Cells were then differentiated, as previously described (Barayuga et al. 2013 (link)), with Neurobasal Medium that was supplemented with 2 mM L-alanyl-L-glutamine, 1X Penicillin Streptomycin and 1x B-27 Serum-Free Supplement (Life Technologies, New York, USA). Retinoic acid in the B-27 supplement induced differentiation.
+ Open protocol
+ Expand
10

Directed Differentiation of iPSCs to Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were cultured in mTeSR1 media (STEMCELL Technologies, Vancouver, Canada; 85851) in 6-cm dishes precoated with Matrigel (Life Technologies, Carlsbad, CA; A1413302) and incubated at 37°C and 5% CO2. At 85% confluence, iPSCs were disaggregated with ReLeSR (STEMCELL Technologies; 05872), passaged into 24-well plates, and allowed to grow for 4 to 5 days to create a monolayer. The differentiation strategy used has been reported previously.11 For differentiation, the culture medium was changed to RPMI 1640 GlutaMAX plus 25 mM HEPES supplemented with B27-minus insulin (Life Technologies; A18956-01) containing CHIR99021 (Tocris Bioscience, Bristol, United Kingdom; 4423, 6 μM as working concentration) from days 0 to 2. On day 2, medium was changed to RPMI-B27-minus insulin containing IWP2 (Tocris Bioscience; 3533, 5μM as working concentration) and incubated until day 4. On day 4, the medium was changed back to normal RPMI GlutaMAX-B27-minus insulin and cells were maintained in this media until beating cardiomyocytes appeared, typically around day 6 or day 8. After beating was seen, iPSC-CMs were maintained in RPMI GlutaMAX medium with B27 serum-free supplement (Life Technologies; 17504-044).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!